Home » Topics » Regulatory » Patents

Patents
RSS

Enanta Pharmaceuticals discloses NS3 protease inhibitors for HCV infection

Dec. 29, 2009

GlaxoSmithKline presents S1P1 receptor agonists as antiarthritic agents

Dec. 28, 2009

Wellstat Therapeutics developing URAT1 inhibitors for the treatment of gout

Dec. 28, 2009

Vitae Pharmaceuticals and Boehringer Ingelheim claim novel antiobesity agents

Dec. 28, 2009

Takeda describes tachykinin antagonists for IBS therapy

Dec. 28, 2009

Roche discloses CPT-2 inhibitors for the treatment of type 2 diabetes

Dec. 28, 2009

Insulin secretion stimulators in development Merck KGaA for type 2 diabetes therapy

Dec. 24, 2009

Novel GK activators for the treatment of diabetes presented by Roche

Dec. 24, 2009

Yakult Honsha discloses novel MMP inhibitors for cancer therapy

Dec. 24, 2009

Takeda describes novel AR antagonists for cancer therapy

Dec. 24, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...